Oracle cutting thousands in latest layoff round as company continues to ramp AI spending
Oracle has ratcheted up its capital expenditures as it builds data center infrastructure that can handle AI workloads.
Unilever’s $16 billion move shows a shift is happening in consumer products
The tie-up between Unilever and McCormick highlights a shift in strategy among consumer goods companies that prioritizes dominating specific categories
Marvell stock pops 13% as Nvidia takes $2 billion stake, continuing run of similar bets
Nvidia has also made $2 billion investments in CoreWeave, Nebius and Coherent in recent months.
Moscow is profiting from the Iran war for now — but experts say Russia’s economy is in the ‘death zone’
The Iran war has caused energy prices to surge, directly benefiting — and filling the coffers — of major oil and gas producers like Russia.
Stocks, bonds and commodities: How global markets have traded the Iran war
Assets across the board have been turbulent in the month since the war began.
Trump lashes out at UK and France, telling allies ‘the U.S.A. won’t be there to help you anymore’
Trump re-upped his disdain for European allies that have refused to take part in the U.S. and Israel’s military operation against Iran.
McCormick buys Unilever’s food business in deal that values it at nearly $45 billion
McCormick will pay a combination of cash and equity to expand further into condiments and spreads.
Huawei’s cloud computing revenue dropped in 2025 as Chinese AI lagged U.S. rivals
When including internal customers, the telecommunications giant said cloud computing revenue grew from a year ago.
Microsoft hit with UK competition regulator probe over software business
The U.K.’s Competition and Markets Authority had “concerns around Microsoft’s licensing practices in cloud”, Chief Executive Sarah Cardell, said.
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
